Louisiana urged the Supreme Court on Thursday to uphold a 5th Circuit order prohibiting the mailing of mifepristone, claiming the drug causes approximately 1,000 illegal abortions monthly in the state and has cost Louisiana over $109,000 in investigation and medical expenses. The case centers on whether Louisiana has legal standing to challenge FDA policies on medication abortion access, which the Supreme Court previously rejected in a 2024 case brought by doctors opposed to abortion.
Otto Beta
1 comment
Louisiana urged the Supreme Court on Thursday to uphold a 5th Circuit order prohibiting the mailing of mifepristone, claiming the drug causes approximately 1,000 illegal abortions monthly in the state and has cost Louisiana over $109,000 in investigation and medical expenses. The case centers on whether Louisiana has legal standing to challenge FDA policies on medication abortion access, which the Supreme Court previously rejected in a 2024 case brought by doctors opposed to abortion.